Hindustan Ultra Care Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 04-11-2024
- Paid Up Capital ₹ 1.26 Cr
as on 04-11-2024
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.34 Cr
as on 04-11-2024
- Revenue 312.69%
(FY 2023)
- Profit 101.63%
(FY 2023)
- Ebitda -30011.59%
(FY 2023)
- Net Worth 1.07%
(FY 2023)
- Total Assets 76.56%
(FY 2023)
About Hindustan Ultra Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.26 Cr.
The company currently has active open charges totaling ₹4.34 Cr.
Girish Agarwal, Rekha Agarwal, and Palak Agrawal serve as directors at the Company.
- CIN/LLPIN
U24290RJ2021PLC073098
- Company No.
073098
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Jan 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Kota, Rajasthan, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Hindustan Ultra Care Limited offer?
Hindustan Ultra Care Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Syringes.
Who are the key members and board of directors at Hindustan Ultra Care?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palak Agrawal  | Director | 22-Jan-2021 | Current |
| Girish Agarwal | Director | 22-Jan-2021 | Current |
| Rekha Agarwal | Director | 22-Jan-2021 | Current |
Financial Performance of Hindustan Ultra Care.
Hindustan Ultra Care Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 312.69% increase. The company also saw a substantial improvement in profitability, with a 101.63% increase in profit. The company's net worth moved up by a moderate rise of 1.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hindustan Ultra Care?
In 2023, Hindustan Ultra Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 16 Mar 2024 | ₹9.40 M | Open |
State Bank Of India Creation Date: 16 Nov 2021 | ₹3.40 Cr | Open |
How Many Employees Work at Hindustan Ultra Care?
Hindustan Ultra Care has a workforce of 13 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hindustan Ultra Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hindustan Ultra Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
